1. Home
  2. FELE vs NAMS Comparison

FELE vs NAMS Comparison

Compare FELE & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Electric Co. Inc.

FELE

Franklin Electric Co. Inc.

HOLD

Current Price

$98.39

Market Cap

4.4B

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$35.44

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FELE
NAMS
Founded
1944
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.6B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FELE
NAMS
Price
$98.39
$35.44
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$103.50
$46.75
AVG Volume (30 Days)
217.8K
1.5M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
1.10%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$2,131,250,000.00
N/A
Revenue This Year
$6.84
$17.96
Revenue Next Year
$3.43
$540.65
P/E Ratio
$125.66
N/A
Revenue Growth
5.44
N/A
52 Week Low
$84.31
$16.79
52 Week High
$111.53
$42.21

Technical Indicators

Market Signals
Indicator
FELE
NAMS
Relative Strength Index (RSI) 50.21 54.59
Support Level $97.53 $34.05
Resistance Level $101.40 $37.25
Average True Range (ATR) 1.94 2.43
MACD -0.30 0.03
Stochastic Oscillator 46.61 47.81

Price Performance

Historical Comparison
FELE
NAMS

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: